z-logo
Premium
An Accessible Organotypic Microvessel Model Using iPSC‐Derived Endothelium
Author(s) -
Ingram Patrick N.,
Hind Laurel E.,
JiminezTorres Jose A.,
Huttenlocher Anna,
Beebe David J.
Publication year - 2018
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201700497
Subject(s) - induced pluripotent stem cell , microbiology and biotechnology , microvessel , chemotaxis , endothelial stem cell , biology , endothelium , cell type , angiogenesis , cell , extracellular matrix , immunology , in vitro , embryonic stem cell , cancer research , biochemistry , receptor , gene , endocrinology
While organotypic approaches promise increased relevance through the inclusion of increased complexity (e.g., 3D extracellular microenvironment, structure/function relationships, presence of multiple cell types), cell source is often overlooked. Induced pluripotent stem cell (iPSC)‐derived cells are potentially more physiologically relevant than cell lines, while also being less variable than primary cells, and recent advances have made them commercially available at costs similar to cell lines. Here, the use of induced pluripotent stem cell‐derived endothelium for the generation of a functional microvessel model is demonstrated. High precision structural and microenvironmental control afforded by the design approach synergizes with the advantages of iPSC to produce microvessels for modeling endothelial biology in vitro. iPSC microvessels show endothelial characteristics, exhibit barrier function, secrete angiogenic and inflammatory mediators, and respond to changes in the extracellular microenvironment by altering vessel phenotype. Importantly, when deployed in the investigation of neutrophils during innate immune recruitment, the presence of the iPSC endothelial vessel facilitates neutrophil extravasation and migration toward a chemotactic source. Relevant cell sources, such as iPSC, combine with organotypic models to open the way for improved and increasingly accessible in vitro tissue, disease, and patient‐specific models.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here